Mean age was 60.9 years, with a nonsignificant trend for greater age in the DOAC group (63.3 vs 56.6 years).
← all excerpts
Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism.
1
—
—